28th Sep 2009 07:00
|
For immediate release |
28 September 2009 |
Futura Medical plc
("Futura" or "the Group" or "the Company")
Appointment of Nominated Adviser and Broker
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, is pleased to announce the appointment of Nomura Code Securities Limited as the Company's nominated adviser and broker with immediate effect.
For any further information please contact:
|
Futura Medical plc |
|
|
James Barder, Chief Executive |
Tel: +44 (0) 1483 685 670 |
|
mail to: [email protected] |
www.futuramedical.co.uk |
|
Nomura Code Securities Limited |
|
|
Charles Walker / Giles Balleny |
Tel:+44 (0)20 7776 1200 |
|
For media enquiries please contact: |
|
|
Buchanan Communications |
|
|
Mark Court / Stasa Filiplic / Jennie Spivey |
Tel: +44 (0) 20 7466 5000 |
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.co.uk
Related Shares:
Futura Medical